This is exactly right.

This is Kate Winkler Dawson, inviting you to listen to brand new episodes of my true crime talk show, Wicked Words.

On each new episode, I interview journalists, podcasters, and filmmakers about the fascinating behind-the-scenes stories from their investigations

into the world of true crime, many of which have never been shared before. So join me and a new

special guest each week for new episodes of wicked words as we dive deep into the stories behind

the stories. New episodes of wicked words are available now wherever you get your podcasts.

From the moment of birth, you begin to age.

The changes are almost entirely internal and imperceptible.

But by your 20s, the sun has probably left its first telltale marks on your most

prominent feature, your face. You start to get tiny lines or wrinkles. Or as dermatologists put it,

you experience photo aging. Usually by your early 30s and with each passing year, those first

fine furrows begin to deepen and multiply.

To some, the lines are signs of character or a merry disposition to be neither fretted over nor fought against.

To many others, though, they are scars, reminders of the disappearance of youth.

Not surprisingly, then, eliminating wrinkles is a roughly $3 billion business in youth conscious America. In the past 15 months, however, we have been told

that much of this energy and enterprise may have been rendered obsolete by a drug that purports to improve skin tone and erase wrinkles.

Its scientific name is all trans-retinoic acid, but most of us know it by its brand name, Retinae.

Once a popular acne cream marketed by Ortho Pharmaceutical, a $600 million a year subsidiary of $9 billion

Johnson and Johnson. Retinae has been hailed by doctors and the press as the first drug, as opposed

to a cosmetic, that shows promise not only in treating the symptoms of aging, but also in actually

reversing part of the process itself. The

The Do you like my Dr.

...